CARMEN LANDAVERDE: Open Payments
NPI 1902093263 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$103,564 in 167 payments from 12 companies in 2025. Trend: 2023 $15,995 · 2024 $47,491 · 2025 $103,564
Speaker / faculty: $55,243Consulting: $19,060Travel & lodging: $11,889Speaker / faculty: $10,800Food & beverage: $6,573
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 34 | $42,555 |
| Intercept Pharmaceuticals, Inc. | 29 | $19,865 |
| Gilead Sciences, Inc. | 27 | $14,085 |
| Ipsen Biopharmaceuticals, Inc | 18 | $13,080 |
| Mirum Pharmaceuticals, Inc. | 32 | $11,182 |
| Boston Scientific Corporation | 8 | $2,295 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $201 |
| HISTOSONICS, INC. | 1 | $140 |
| Novo Nordisk Inc | 2 | $50 |
| Eton Pharmaceuticals, Inc. | 1 | $45 |
Products named: REZDIFFRA, OCALIVA, IQIRVO, Livdelzi, Livmarli, TheraSphere Y90 Glass Microspheres 10 GBq, Epclusa, XIFAXAN.
Industry payments across TX — which companies pay providers there.
